Dagmar Jirova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dagmar Jirova has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Kristina Kejlová
Centre of Toxicology and Health Safety, National Institute of Public Health, Šrobárova 49/48, 100 00 Prague, Czech Republic
2 shared publications - Lada Svobodová
Centre of Toxicology and Health Safety, National Institute of Public Health, Prague, Czech Republic
2 shared publications - Marketa Dvorakova
National Institute of Public Health, Šrobárova 48, 100 42 Prague, Czech Republic
2 shared publications - Adam Vavrouš
National Institute of Public Health, Srobarova 49/48, 100 00 Prague 10, Czech Republic
1 shared publication - Barbora Hosikova
Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University, 77900 Olomouc, Czech Republic
1 shared publication - Danuše Očadlíková
Centre of Toxicology and Health Safety, National Institute of Public Health, Šrobárova 49/48, 100 00 Prague, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 21 December 2023
- Published by MDPI AG in Journal of Xenobiotics
- Vol. 14 (1) , 15-30
The Potential for Genotoxicity, Mutagenicity and Endocrine Disruption in Triclosan and Triclocarban Assessed through a Combination of In Vitro Methods
Triclosan and Triclocarban, preservatives widely used in cosmetics and other consumer products, underwent evaluation using a battery of new-approach methodologies in vitro (NAMs). Specifically, the Microplate Ames Test (MPF™ Test, Xenometrix, Allschwil, Switzerland) was employed to assess mutagenicity, the Comet assay in vitro on the HaCat cell line and the Mammalian Chromosome Aberration Test were utilized to evaluate genotoxicity, and the XenoScreen® YES/YAS assay was applied to investigate endocrine disruption. The chemicals did not exhibit any positive responses for mutagenicity. However, the mammalian chromosome aberration test identified both chemicals as being positive for genotoxicity at 10 µg/mL. In the Comet assay, the percentage of DNA in the tail significantly increased in a concentration-dependent manner (at 5 and 10 µg/mL for Triclosan, at 2.5, 5, and 10 µg/mL for Triclocarban). The positive response depended on the increasing concentration and the duration of exposure. Triclosan, but not Triclocarban in any of the endocrine assays performed, indicated a potential for endocrine activity in the anti-estrogenic and anti-androgenic assays. The positive in vitro results detected were obtained for concentrations relevant to final products. The alarming findings obtained with the use of new-approach methodologies (NAMs) justify the current precautionary regulatory approach, limiting the use of these preservatives.
- 21 December 2023
- Published by MDPI AG in Journal of Xenobiotics
- Vol. 14 (1) , 15-30
Open AccessThe Potential for Genotoxicity, Mutagenicity and Endocrine Disruption in Triclosan and Triclocarban Assessed through a Combination of In Vitro Methods
Triclosan and Triclocarban, preservatives widely used in cosmetics and other consumer products, underwent evaluation using a battery of new-approach methodologies in vitro (NAMs). Specifically, the Microplate Ames Test (MPF™ Test, Xenometrix, Allschwil, Switzerland) was employed to assess mutagenicity, the Comet assay in vitro on the HaCat cell line and the Mammalian Chromosome Aberration Test were utilized to evaluate genotoxicity, and the XenoScreen® YES/YAS assay was applied to investigate endocrine disruption. The chemicals did not exhibit any positive responses for mutagenicity. However, the mammalian chromosome aberration test identified both chemicals as being positive for genotoxicity at 10 µg/mL. In the Comet assay, the percentage of DNA in the tail significantly increased in a concentration-dependent manner (at 5 and 10 µg/mL for Triclosan, at 2.5, 5, and 10 µg/mL for Triclocarban). The positive response depended on the increasing concentration and the duration of exposure. Triclosan, but not Triclocarban in any of the endocrine assays performed, indicated a potential for endocrine activity in the anti-estrogenic and anti-androgenic assays. The positive in vitro results detected were obtained for concentrations relevant to final products. The alarming findings obtained with the use of new-approach methodologies (NAMs) justify the current precautionary regulatory approach, limiting the use of these preservatives.
- Open Access
- 13 October 2022
- Published by Elsevier in Current Research in Toxicology
- Vol. 3, 100090
New approach methods for assessing indoor air toxicity
- 13 October 2022
- Published by Elsevier in Current Research in Toxicology
- Vol. 3, 100090
Open AccessNew approach methods for assessing indoor air toxicity